Production and on-line acetylcholinesterase bioactivity profiling of chemical and biological degradation products of tacrine
- 1 November 2010
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 53 (3) , 609-616
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrineJournal of Pharmaceutical and Biomedical Analysis, 2008
- Acetylcholinesterase inhibitors for Alzheimer’s disease: anti-inflammatories in acetylcholine clothing!Age and Ageing, 2006
- Development of validated stability-indicating assay methods—critical reviewJournal of Pharmaceutical and Biomedical Analysis, 2002
- Acetylcholinesterase in Alzheimer's diseaseMechanisms of Ageing and Development, 2001
- Determination of tacrine and its metabolites in human plasma and urine by high-performance liquid chromatography and fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- TacrineThe Lancet, 1995
- Tacrine: First Drug Approved for Alzheimer's DiseaseAnnals of Pharmacotherapy, 1994
- A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group1994
- An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro: Studies with human and rat liver microsomesBiochemical Pharmacology, 1993
- High-performance liquid chromatography for the determination of tacrine and its metabolites in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1990